DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Type I diabetes mellitus	R-HSA-5683209	map04940	tyloxapol	5281416	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	tyloxapol	5281416	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	tyloxapol	5281416	drug-path
Calcium signaling pathway	R-HSA-381753	map04020	tyloxapol	5281416	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	metyrapone	4174	drug-path
Hematopoietic cell lineage	R-HSA-173752	map04640	metyrapone	4174	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	metyrapone	4174	drug-path
Olfactory transduction	R-HSA-9751605	map04740	metyrapone	4174	drug-path
Axon guidance	R-HSA-422475	map04360	metyrapone	4174	drug-path
p53 signaling pathway	R-HSA-168638	map04115	metyrapone	4174	drug-path
Asthma	R-HSA-444620	map05310	metyrapone	4174	drug-path
Chemokine signaling pathway	R-HSA-168638	map04062	metyrapone	4174	drug-path
Allograft rejection	R-HSA-9679028	map05330	metyrapone	4174	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	metyrapone	4174	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	metyrapone	4174	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	valinomycin	3000706	drug-path
Alzheimer's disease	R-HSA-1643685	0	valinomycin	3000706	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	valinomycin	3000706	drug-path
Huntington's disease	R-HSA-1643685	0	valinomycin	3000706	drug-path
Olfactory transduction	R-HSA-9751605	map04740	valinomycin	3000706	drug-path